AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...
Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...
Amid growing concerns over drug abuse, cultism, and electoral violence, the Centre for Peace and Environmental Justice (CEPEJ-Africa) has unveiled its 2026 strategic plan aimed at promoting ...
Hopstem has already completed phase 1 testing of hNPC01 in China, with encouraging results, and says it has now reached ...
Variant Bio, a genomics-driven AI drug discovery company, today announced the appointment of Craig T. Basson, MD, PhD, as Chief Medical Officer and President of R&D. Dr. Basson brings more than 25 ...
Our End-of-Phase 2 meeting with FDA was productive and provided Lexicon with the insights needed to design a robust Phase 3 program, with the goal of making the first non-opioid DPNP medicine ...
Nestled in the Pegasus Park complex in Dallas, a globally recognized center for life science innovation, business and social ...
Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback